3,5-Di-tert-butylaniline → N-{3,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-methoxybenzamide

HRID 421153

반응식

HRID 421153 반응식
[CH3:1][O:2][C:3]1[CH:11]=[C:7]([C:8]([OH:10])=O)[C:6]([OH:12])=[CH:5][CH:4]=1.[CH3:13][C:14]([C:17]1[CH:18]=[C:19]([CH:21]=[C:22]([C:24]([CH3:27])([CH3:26])[CH3:25])[CH:23]=1)[NH2:20])([CH3:16])[CH3:15]>>[CH3:16][C:14]([C:17]1[CH:18]=[C:19]([NH:20][C:8](=[O:10])[C:7]2[CH:11]=[C:3]([O:2][CH3:1])[CH:4]=[CH:5][C:6]=2[OH:12])[CH:21]=[C:22]([C:24]([CH3:27])([CH3:26])[CH3:25])[CH:23]=1)([CH3:13])[CH3:15]

참가 물질

3

반응물 2

HCID 754193,5-Di-tert-butylanilineHCID 757875-Methoxysalicylic Acid

생성물 1

HCID 66657198N-{3,5-Bis[(1,1-dimethyl)ethyl]phenyl}-2-hydroxy-5-methoxybenzamide수율 12.7%

실험 절차

Using 5-methoxysalicylic acid and 3,5-bis[(1,1-dimethyl)ethyl]aniline as the raw materials, the same operation as the example 16 gave the title compound.

출처 및 근거

ORD 기록
ord-b2c55289a3a143c6b8cc4321c379eb5f
출처 데이터셋
uspto-grants-2012_01
특허 번호
US08097759B2

연결된 노트

불러오는 중…